Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 1999 by FDA Office of Orphan Products Development.
Recruitment status was Active, not recruiting

Sponsor:

Collaborator:

National Jewish Health

Information provided by:

FDA Office of Orphan Products Development

ClinicalTrials.gov Identifier:

NCT00004689

First received: February 24, 2000

Last updated: June 23, 2005

Last verified: February 1999

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given